These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. European Commission considers revisions to clinical trials directive. Mason E J Natl Cancer Inst; 2010 Mar; 102(5):292-4, 297. PubMed ID: 20173121 [No Abstract] [Full Text] [Related]
4. Expanded clinical trials of treatments for multiple sclerosis. The Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis of The National Multiple Sclerosis Society. Whitaker JN Ann Neurol; 1993 Dec; 34(6):755-6. PubMed ID: 8250523 [No Abstract] [Full Text] [Related]
5. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program. Stark Y Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251 [No Abstract] [Full Text] [Related]
6. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard? Boers M Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813 [No Abstract] [Full Text] [Related]
9. Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Harrington KJ; Billingham LJ; Brunner TB; Burnet NG; Chan CS; Hoskin P; Mackay RI; Maughan TS; Macdougall J; McKenna WG; Nutting CM; Oliver A; Plummer R; Stratford IJ; Illidge T Br J Cancer; 2011 Aug; 105(5):628-39. PubMed ID: 21772330 [No Abstract] [Full Text] [Related]
10. Increasing challenges to trial recruitment: Is it time to change the inclusion criteria for investigational compounds, not just for study participants? Eyal AD; Eyal S Epilepsia; 2024 Jul; 65(7):1907-1915. PubMed ID: 38713479 [No Abstract] [Full Text] [Related]
12. 27th Annual JPMorgan Healthcare Conference--Antisoma and Keryx Biopharmaceuticals. Croasdell G; Gale S IDrugs; 2009 Mar; 12(3):152-4. PubMed ID: 19333892 [No Abstract] [Full Text] [Related]
13. Premarketing trials: too few patients. Prescrire Int; 2014 Oct; 23(153):251. PubMed ID: 25964980 [No Abstract] [Full Text] [Related]
14. American society of clinical oncology - 45th annual meeting. Part 2. Lakeram M; Kibble A IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155 [No Abstract] [Full Text] [Related]
15. American society of clinical oncology - 45th annual meeting. Part 1. Gale S IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154 [No Abstract] [Full Text] [Related]
16. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola. Cavaleri M; Thomson A; Salmonson T; Hemmings RJ Clin Trials; 2016 Feb; 13(1):101-4. PubMed ID: 26768561 [No Abstract] [Full Text] [Related]
17. Comparative requirements for exploratory clinical trials -- eIND, eCTA and microdosing. Muller PY Adv Drug Deliv Rev; 2011 Jun; 63(7):511-7. PubMed ID: 21034787 [TBL] [Abstract][Full Text] [Related]
18. [Problems of clinical trials of new drugs as a basis of modern evidence-based medicine]. Moiseev VS Ter Arkh; 2008; 80(12):5-10. PubMed ID: 19227898 [No Abstract] [Full Text] [Related]